Global Precision Medicine Market by Technology Types, Application, & Regions Forecasted to 2025

  • Category : Healthcare and Pharma
  • |
  • ID : 559884
  • |
  • Date : June 2018
  • |
  • No of Pages: 122
  • |
  • Publisher : Intellectual Research Partners

The Global Precision Medicine Market is estimated to grow at a CAGR of XX% by 2025. This report features the market growth analysis and forecasting for the growth and revenue up to 2025 allied with the Precision Medicine market. The market size estimations have been provided in terms of value (USD million). The global Precision Medicine industry report also identifies major market players and provides analysis in terms of company overview, Financials, products & services, market trends, recent developments and growth strategies.

Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient.

The Precision Medicine market is segmented on the Technology Type, Applications and regions.

Regionally, North America, Latin America, Europe, Asia Pacific, And The Middle East & Africa constitute the key market segments. Europe was the dominant region due to high demand in Precision Medicine segment followed by North America

The key players? are-

F-HOFFMANN LA ROCHE
PFIZER, INC.,
TEVA PHARMACEUTICALS,
NOVARTIS AG,
QIAGEN, INC.,
MEDTRONIC,
ILLUMINA, INC.
QUEST DIAGNOSTICS.

Key benefit of this report:
* This report provides current market trends and future growth expectations.
* This report examines the market size and changing competitive dynamics
* It covers information regarding key drivers, challenges or restraining market growth
* It provides a five-year forecast assessed on the basis market value chain, porter's five forces, and supply chain management.
* Market factor analysis delivers treasured information regarding the possible purchasers and suppliers and understanding the stakeholders involved.
* This report incorporates data regarding companies and business decision by having complete insights on the markets and by creating in depth analysis of market segments.

Target audience:
* Precision Medicine manufacturers/suppliers
* Importers and exporters of Precision Medicine
* Raw material suppliers
* Dealers
* End users

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

2 DEMOGRAPHIC OVERVIEW

3 RESEARCH METHODOLOGY
3.1 INTRODUCTION
3.1.1 PRIMARY RESEARCH
3.1.2 SECONDARY RESEARCH
3.1.3 FORECASTING MODEL
3.1.4 MARKET SIZE ESTIMATION
3.2 MARKET DYNAMICS [SWOT ANALYSIS]
3.2.1 STRENGTH
3.2.2 WEAKNESS
3.2.3 OPPORTUNITY
3.2.4 THREAT

4 PREMIUM INSIGHTS
4.1 BIGGEST MARKETS
4.2 MARKET SHARE ANALYSIS
4.3 HIGH GROWTH MARKETS
4.4 HISTORICAL VS UPCOMING TRENDS

5 MARKET OVERVIEW
5.1 MARKET DRIVERS
5.2 RESTRAINTS
5.3 OPPORTUNITIES
5.4 CHALLENGES

6 MARKET FACTOR ANALYSIS
6.1 PORTER?S FIVE FORCES
6.2 VALUE CHAIN ANALYSIS
6.3 PESTEL ANALYSIS

7 GLOBAL PRECISION MEDICINE MARKET BY TECHNOLOGY TYPES
7.1 INTRODUCTION
7.2 DRUG DISCOVERY
7.3 BIO INFORMATICS
7.4 BIG DATA ANALYTICS
7.5 COMPANION DIAGNOSTICS

8 GLOBAL PRECISION MEDICINE MARKET BY APPLICATION
8.1 INTRODUCTION
8.2 ONCOLOGY
8.3 HEMATOLOGY
8.4 CARDIOLOGY
8.5 NEUROLOGY

9 GLOBAL PRECISION MEDICINE MARKET BY REGION
9.1 NORTH AMERICA
9.1.1 US
9.1.2 CANADA
9.2 EUROPE
9.2.1 GERMANY
9.2.2 ITALY
9.2.3 FRANCE
9.2.4 SPAIN
9.2.5 UK
9.2.6 REST OF EUROPE
9.3 APAC
9.3.1 CHINA
9.3.2 JAPAN
9.3.3 INDIA
9.3.4 REST OF ASIA-PACIFIC
9.4 REST OF THE WORLD

10 MARKET TRENDS & COMPETITIVE ANALYSIS

11 COMPANY PROFILES
11.1 F-HOFFMANN LA ROCHE
11.2 PFIZER, INC
11.3 TEVA PHARMACEUTICALS
11.4 NOVARTIS AG
11.5 QIAGEN, INC
11.6 MEDTRONIC
11.7 ILLUMINA, INC
11.8 QUEST DIAGNOSTICS





Content are not available

Choose License Type